You are here

Home > Current news > News > Internationalization

Internationalization

HIGHLIGHTS: Results of the ‘Study on investment in the life sciences and healthcare industry in Catalonia 2020’, alliance between Esteve and Leitat, and new Catalan Public Health Secretary

24.07.2020

The BioRegion is advancing at a good pace in the beginning of the ‘new normality’

Biocat 2019 Report of activities published

22.07.2020

Bio€quity being held in Barcelona for the first time and the ‘Here comes your lead’ acceleration program, among the most noteworthy milestones of the year

Investments in start-ups in the life sciences and healthcare in Catalonia surpass €100M for the fourth year in a row

02.07.2020

The Study on investment in the life sciences and healthcare industry in Catalonia 2020 showcases the robust health of the ecosystem, which has raised almost as much capital in the first half of 2020 as it did in all the rounds in 2019

HIGHLIGHTS: BioRegion continues fight Covid-19, Catalan pharmaceutical corporations see profits soar in the first quarter and new investment operations announced

26.05.2020

Advances in Covid-19 research are still the main headlines this month

More than 50 companies from the BioRegion to participate in 4YFN

28.01.2020

18 of them will have exhibitions in the space coordinated by Biocat along with ACCIÓ, Barcelona Tech City and CataloniaBio & HealthTech

Biocat 2018 Report of activities published

22.07.2019

The presentation of the Biocat Report and new acceleration projects, among the most noteworthy milestones of the year

Biocat takes the BioRegion of Catalonia to Boston and London

19.06.2019

The organization presented the ecosystem at Barcelona Innovation Day and Barcelona London Day

HIGHLIGHTS: New funds, Mind the Byte begins bankruptcy proceedings, rounds in biotech firms and advances in research

25.04.2019

The goodbye to Josep Esteve added a bittersweet note to a month of new hires and investment news

HIGHLIGHTS: New investment fund and high-impact advances in HIV and cancer

28.03.2019

Asabys kicks off with €30 million, IrsiCaixa announces 2nd case of HIV in remission in the world and Peptomyc makes advances with its oncology drug

HIGHLIGHTS: Licenses, calls in the sector, 5G, mini-kidneys, new hires and goodbyes

28.02.2019

Results from publicly traded companies, European grants and scientific publications round out the headlines for February in the BioRegion

Developed by Drauta